Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Biological characteristics of A-176120, a potent FPP mimetic with promise as a cancer therapeutic

July 12, 2000

AlphaOne enters agreement with Dana-Farber for tumor suppressor gene

July 12, 2000

Maxim licenses caspase-activating anticancer compounds to BioChem Pharma

July 11, 2000

Tumor antigen-specific chimeric proteins from Idec promote antitumor immune response

July 11, 2000

Shortened Taxol regimen approved by FDA for advanced ovarian cancer

July 11, 2000

Chemoprotective effects of KF-41399 demonstrated in nimustine-treated mice

July 11, 2000

New benzazepine selectively targets tumor cells and induces G2/M arrest and apoptosis

July 11, 2000

Angiostatin combined with radiation therapy enters phase I trials

July 11, 2000

SkyePharma grants Paladin exclusive Canadian rights for DepoCyt

July 10, 2000

Aronex files NDA amendment for Atragen as treatment for APL

July 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...